144 ·Filed Jul 2, 2026

QURE

uniQure N.V.
NEUTRAL
Impact 2/10
Horizonimmediate Processed3mo ago SEC0001973379-26-000264
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

The CEO's Form 144 signals intent to sell a modest block under a pre-existing 10b5-1 plan. This is not actionable as a negative signal — the plan was adopted nine months ago and recent sells have not been accompanied by negative news. Continue to monitor for any change in the trading plan (e.g., unscheduled or accelerated sales) or unexpected insider departures, but no immediate read-through.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d ⚠ clustered
QURE ▲ +0.91% at T+20d
NEUTRAL call ✓ call won +0.91% · α vs SPY +1.32% · entry $41.81 → $42.19
Next anchor: T+60d due 4d ago
Latest observation: T+57 -82.55% FF3 residual α
Entry anchored
Jul 2, 03:59 PM ET
via exchange tick
T+1d
-1.08%
call -1.08% · α -1.95%
$41.36
settled 3mo ago
T+5d
+6.39%
call +6.39% · α +5.46%
$44.48
settled 3mo ago
T+20d
+0.91%
call +0.91% · α +1.32%
$42.19
settled 2mo ago
T+60d
—
call — · α —
—
due 4d ago

Price Chart

Loading chart...

Executive Summary

CEO Matthew Kapusta filed a Form 144 to sell 21,082 ordinary shares valued at ~$952K. The notice indicates the sale is part of an established 10b5-1 trading plan adopted in October 2025 and cites a stock option exercise. This is a pre-planned sale with no new discretionary insider signal, and the overall insider activity (including recent prior sells) is consistent with plan-driven liquidity.

Key Facts

  • Reporting person: Matthew C. Kapusta, CEO and Managing Director of uniQure N.V.
  • Proposed sale: 21,082 ordinary shares via Citigroup Global Markets
  • Estimated value: ~$951,932 (approx. 0.034% of market cap at $2.8B)
  • Shares to be sold after filing: 21,082, with balance held of 63,067,485
  • Trading plan: 10b5-1 plan adopted October 5, 2025 — sale is pre-scheduled
  • Recent insider sells (4 sells totaling $2.1M in 30 days) are also plan-related, not opportunistic

Financial Impact

$951,932 proposed sale, representing approximately 0.034% of market cap — immaterial

dilution

Risk Factors

  • Insider selling under a 10b5-1 plan could still precede negative catalysts if the plan was set at a high stock price level — but here the plan was adopted ~9 months ago, reducing that risk
  • CEO selling at all may cause short-term retail concern despite the plan context

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
76% bullish (21 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001973379-26-000264
Document: 0001973379-26-000264-index.html0001973379-26-000264
Document: 0001973379-26-000264.txt0001973379-26-000264
32 reports for QURE
Performance horizon
67% Hit rate 6 of 9 directional calls best @ T+20▲ +27.15%Jul 29, 2026
Filters
Rows
Reports for QURE — sortable, filterable
TypeNow
Sep 2, 2026
4w ago
8-K
BULLISH ★ 7/10
$46.23 $44.47▼ −3.81%▼ −2.85%$23.46 (−49.25%)
Jul 29, 2026
9w ago
8-K
BULLISH ★ 8/10
$40.07 $44.24▲ +10.41%▲ +4.88%$23.46 (−41.45%)
Jul 7, 2026
12w ago
Insider Cluster
BEARISH ★ 5/10
$41.41 $41.52▼ −0.27%▲ +0.29%$23.46 (+43.35%)
Jul 2, 2026
13w ago
Insider Cluster
BEARISH ★ 4/10
$41.81 $44.48▼ −6.39%▼ −5.46%$23.46 (+43.89%)
Jul 2, 2026
13w ago
Insider Cluster
MIXED ★ 5/10
$41.81 $44.48▲ +6.39%▲ +5.46%$23.46 (−43.89%)
Jul 2, 2026
13w ago
144
NEUTRAL ★ 2/10
$41.81 $44.48▲ +6.39%▲ +5.46%$23.46 (−43.89%)
Jun 30, 2026
13w ago
144
NEUTRAL ★ 2/10
$45.17 $41.41▼ −8.32%▼ −8.59%$23.46 (−48.06%)
Jun 25, 2026
14w ago
144
BEARISH ★ 5/10
$47.51 $41.81▲ +12.00%▲ +14.16%$23.46 (+50.62%)
Jun 24, 2026
14w ago
424B5
MIXED ★ 6/10
$49.10 $45.17▼ −8.00%▼ −9.56%$23.46 (−52.22%)
Jun 24, 2026
14w ago
144
NEUTRAL ★ 2/10
$49.10 $45.17▼ −8.00%▼ −9.56%$23.46 (−52.22%)
Showing 10 of 32

US Market Status

Market Closed — Opens Mon (64h 21m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access